33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.55%
Revenue growth similar to GTLB's 7.85%. Walter Schloss would see if both companies share industry tailwinds.
8.14%
Gross profit growth similar to GTLB's 8.42%. Walter Schloss would assume both firms track common industry trends.
60.83%
EBIT growth above 1.5x GTLB's 32.70%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
61.13%
Operating income growth above 1.5x GTLB's 32.70%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
70.37%
Positive net income growth while GTLB is negative. John Neff might see a big relative performance advantage.
-110.47%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-110.47%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.84%
Slight or no buybacks while GTLB is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.84%
Slight or no buyback while GTLB is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
49.55%
OCF growth under 50% of GTLB's 135.71%. Michael Burry might suspect questionable revenue recognition or rising costs.
55.30%
FCF growth under 50% of GTLB's 134.85%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
88.33%
10Y revenue/share CAGR under 50% of GTLB's 278.03%. Michael Burry would suspect a lasting competitive disadvantage.
88.33%
5Y revenue/share CAGR under 50% of GTLB's 278.03%. Michael Burry would suspect a significant competitive gap or product weakness.
35.59%
3Y revenue/share CAGR under 50% of GTLB's 145.29%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
166.35%
10Y OCF/share CAGR under 50% of GTLB's 808.74%. Michael Burry would worry about a persistent underperformance in cash creation.
166.35%
Below 50% of GTLB's 808.74%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
154.90%
3Y OCF/share CAGR under 50% of GTLB's 5315.73%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
87.21%
Net income/share CAGR at 75-90% of GTLB's 103.99%. Bill Ackman would press for strategic moves to boost long-term earnings.
87.21%
5Y net income/share CAGR at 75-90% of GTLB's 103.99%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
97.82%
3Y net income/share CAGR 75-90% of GTLB's 111.44%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
182.87%
Below 50% of GTLB's 378.26%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
182.87%
Below 50% of GTLB's 378.26%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-46.77%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.94%
AR growth well above GTLB's 40.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.16%
Inventory is declining while GTLB stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.61%
Asset growth at 50-75% of GTLB's 11.71%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
6.12%
50-75% of GTLB's 9.59%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-6.60%
We’re deleveraging while GTLB stands at 53.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.82%
Our R&D shrinks while GTLB invests at 2.50%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.35%
We cut SG&A while GTLB invests at 2.63%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.